RedHill Biopharma (RDHL) Cash & Equivalents (2011 - 2026)
RedHill Biopharma's Cash & Equivalents was $5.16 million in the quarter ended Jun 30, 2026, up 11.7% from $4.62 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Cash & Equivalents (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, Cash & Equivalents at RedHill Biopharma came in at $3.97 million, down 14.0% from the prior year.
- Cash & Equivalents has now declined for three consecutive years, with a five-year compound annual growth rate of -32.9% (years ended Dec 2020 to Dec 2025).
- In earlier years, Cash & Equivalents was $4.62 million in the year ended Dec 31, 2024 (-76.9%), $19.97 million in the year ended Dec 31, 2023 (-32.3%), $29.47 million in the year ended Dec 31, 2022 (unchanged) and $29.47 million in the year ended Dec 31, 2021 (+0.6%).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Cash & Equivalents since the quarter ended Jun 30, 2024.
- Compared with a year earlier, Cash & Equivalents was higher in 1 of the last four quarters, with an average decline of 14.0%.
- The best year-over-year quarter for Cash & Equivalents over five years was the quarter ended Jun 30, 2026 (growth of 11.7%); the worst was the quarter ended Jun 30, 2023 (a decline of 76.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - | 5.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.16 Mn |
| Dec 31, 2025 | 3.97 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Jun 30, 2024 | 7.28 Mn |
| Dec 31, 2023 | 5.57 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 17.57 Mn |
| Dec 31, 2022 | 19.97 Mn |
| Sep 30, 2022 | 15.20 Mn |
| Jun 30, 2022 | 29.47 Mn |
| Mar 31, 2022 | 28.85 Mn |
| Dec 31, 2021 | 29.47 Mn |
| Sep 30, 2021 | 23.25 Mn |
| Jun 30, 2021 | 75.97 Mn |
| Mar 31, 2021 | 75.97 Mn |
| Dec 31, 2020 | 29.30 Mn |
| Sep 30, 2020 | 29.02 Mn |
| Jun 30, 2020 | 81.61 Mn |
| Mar 31, 2020 | 81.61 Mn |
API Access
RedHill Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();